Key Takeaways
- Angelini Ventures leads a €12 million investment in Serenis to enhance digital health services.
- Serenis connects over 170,000 individuals with 2,500 licensed professionals, experiencing rapid growth.
- The investment aims to advance technology-driven mental health solutions and expand corporate wellness programs.
Investment Details and Impact
Angelini Ventures, the corporate venture firm of Angelini Industries, has announced a significant €12 million follow-on investment in Serenis, a leading company in Italy focused on mental health and wellbeing services. This funding, co-led by CDP Venture Capital, aims to enhance Serenis’ digital health offerings and assert its leadership in providing transformative solutions for corporate clients.
Founded in 2021 by Silvia Wang and Daniele Francescon, Serenis has rapidly emerged as one of Europe’s fastest-growing platforms for mental and physical wellbeing. It boasts a network of over 2,500 licensed professionals, including psychotherapists, psychiatrists, and nutritionists, and has successfully supported more than 170,000 individuals through approximately 1.5 million therapy sessions. Having expanded its workforce to 65 employees, Serenis now serves over 250 companies, benefiting more than 300,000 employees via corporate wellness programs for clients such as Nestlé and Leroy Merlin.
Serenis has shown impressive revenue growth, increasing from €2 million in 2022 to €25 million in 2024, with projections exceeding €40 million in 2025. The company’s hybrid approach uses proprietary digital technology to connect users with qualified therapists, effectively breaking down accessibility barriers and tackling the stigma surrounding mental health disorders.
The latest investment is part of Angelini Ventures’ ongoing commitment to mental and brain health, aligning with previous investments in therapeutics and medical technology solutions. Elia Stupka, Managing Director of Angelini Ventures and a board member of Serenis, emphasized the importance of accessible mental and physical wellbeing, stating, “Investing in Serenis means believing that mental and physical wellbeing should be accessible to everyone.”
Silvia Wang, the founder of Serenis, highlighted that the investment underscores their growth trajectory and the potential for further expansion in digital mental health initiatives. This funding exemplifies how Angelini Ventures supports innovative solutions designed to address pressing healthcare challenges.
Serenis aims to dismantle various barriers—economic, technological, social, and cultural—that hinder access to mental healthcare. As a dual function platform and licensed medical center, it provides a comprehensive range of services including psychotherapy, psychiatry, nutrition coaching, and tailored psychological programs through its user-friendly app.
As Angelini Industries continues to diversify its investments across BioTech and HealthTech, this partnership with Serenis reflects its strategy to champion innovative approaches in mental health care, aiming to make a significant impact on the industry and improve access to services in Italy and beyond.
The content above is a summary. For more details, see the source article.
